Catalyst Wire Dossier Catalyst Wire Dossier

Defactinib hydrochloride

defactinib hydrochloride · Verastem Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Defactinib hydrochloride, covering 2025-05-08 to 2025-05-08. Get the full timeline:

Most recent: FDA Approved: AVMAPKI FAKZYNJA CO-PACK — Original Application (Verastem Inc.)

See pricing